Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Cheah, Hong Leong ^a   Lim, Vuanghao ^a   Sandai, Doblin ^a  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CAFFEIC ACID; CINNAMIC ACID; FLUCONAZOLE; GALLIC ACID; ISOCITRATE LYASE; ITACONIC ACID; QUERCETIN; ROSMARINIC ACID; RUTOSIDE; ANTIFUNGAL AGENT; CAFFEIC ACID DERIVATIVE; CINNAMIC ACID DERIVATIVE; DEPSIDE; ENZYME INHIBITOR; FUNGAL PROTEIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBON SOURCE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG STRUCTURE; ENZYME ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN TARGETING; TOXICITY TESTING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; APIGENIN; CAFFEIC ACIDS; CANDIDA ALBICANS; CINNAMATES; DEPSIDES; ENZYME INHIBITORS; FUNGAL PROTEINS; MICROBIAL SENSITIVITY TESTS;

EID: 84899731549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095951     Document Type: Article

References (47)

1. Pfaller MA, Diekema DJ (2010) Epidemiology of Invasive Mycoses in North America. Currr Rev Microbiol 36: 1-53. doi:10.3109/10408410903241444.
2. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, et al. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503-535. doi:10.1086/596757.
3. Perlroth J, Choi B, Spellberg B (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45: 321-346. doi:10.1080/13693780701218689. (Pubitemid 46839802)
4. Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4: 119-128. doi:10.4161/viru.22913.
5. Fleck CB, Schöbel F, Brock M (2011) Nutrient acquisition by pathogenic fungi: nutrient availability, pathway regulation, and differences in substrate utilization. Int J Med Microbiol 301: 400-407. doi:10.1016/j.ijmm. 2011.04.007.
6. Chandrasekar P (2011) Management of invasive fungal infections: a role for polyenes. J Antimicrob Chemother 66: 457-465. doi:10.1093/jac/dkq479
7. Brock M (2009) Fungal metabolism in host niches. Curr Opin Microbiol 12: 371-376. doi:10.1016/j.mib.2009.05.004.
8. Ene IV, Adya AK, Wehmeier S, Brand AC, MacCallum DM, et al. (2012) Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol 14: 1319-1335. doi:10.1111/j.1462-5822.2012. 01813.x.
9. Lorenz MC, Fink GR (2002) Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryotic Cell 1: 657-662. (Pubitemid 36557725)
10. Dunn MF, Ramírez-Trujillo JA, Hernández-Lucas I (2009) Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiol (Reading, Engl) 155: 3166-3175. doi:10.1099/mic.0. 030858-0.
11. Kondrashov FA, Koonin EV, Morgunov IG, Finogenova TV, Kondrashova MN (2006) Evolution of glyoxylate cycle enzymes in Metazoa: evidence of multiple horizontal transfer events and pseudogene formation. Biol Direct 1: 31. doi:10.1186/1745-6150-1-31.
12. Fernández-Arenas E, Cabezón V, Bermejo C, Arroyo J, Nombela C, et al. (2007) Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction. Mol Cell Proteomics 6: 460-478. doi:10.1074/mcp.M600210-MCP200. (Pubitemid 46554541)
13. Marcil A, Gadoury C, Ash J, Zhang J, Nantel A, et al. (2008) Analysis of PRA1 and its relationship to Candida albicans- macrophage interactions. Infect Immun 76: 4345-4358. doi:10.1128/IAI.00588-07.
14. Lorenz MC, Fink GR (2001) The glyoxylate cycle is required for fungal virulence. Nature 412: 83-86. doi:10.1038/35083594. (Pubitemid 32851514)
15. Prigneau O, Porta A, Poudrier JA, Colonna-Romano S, Noël T, et al. (2003) Genes involved in beta-oxidation, energy metabolism and glyoxylate cycle are induced by Candida albicans during macrophage infection. Yeast 20: 723-730. doi:10.1002/yea.998. (Pubitemid 36764057)
16. Lorenz MC, Bender JA, Fink GR (2004) Transcriptional Response of Candida albicans upon Internalization by Macrophages. Eukaryotic Cell 3: 1076-1087. doi:10.1128/EC.3.5.1076-1087.2004. (Pubitemid 39385215)
17. Fradin C, Kretschmar M, Nichterlein T, Gaillardin C, d'Enfert C, et al. (2003) Stage-specific gene expression of Candida albicans in human blood. Mol Microbiol 47: 1523-1543. (Pubitemid 36363337)
18. Ebel F, Schwienbacher M, Beyer J, Heesemann J, Brakhage AA, et al. (2006) Analysis of the regulation, expression, and localisation of the isocitrate lyase from Aspergillus fumigatus, a potential target for antifungal drug development. Fungal Genet Biol 43: 476-489. doi:10.1016/j.fgb.2006.01.015. (Pubitemid 43729189)
19. Gengenbacher M, Rao SPS, Pethe K, Dick T (2010) Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiol (Reading, Engl) 156: 81-87. doi:10.1099/mic.0.033084-0.
20. Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S (2010) Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. PNAS 107: 9819-9824. doi:10.1073/pnas.1000715107.
21. Krátký M, Vinšová J (2012) Advances in mycobacterial isocitrate lyase targeting and inhibitors. Curr Med Chem 19: 6126-6137.
22. Van Schaik EJ, Tom M, Woods DE (2009) Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials. Infect Immun 77: 4275-4283. doi:10.1128/IAI.00609-09.
23. Van Acker H, Sass A, Bazzini S, De Roy K, Udine C, et al. (2013) Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS ONE 8: e58943. doi:10.1371/journal.pone.0058943.
24. Cruz AH da S, Brock M, Zambuzzi-Carvalho PF, Santos-Silva LK, Troian RF, et al. (2011) Phosphorylation is the major mechanism regulating isocitrate lyase activity in Paracoccidioides brasiliensis yeast cells. FEBS J 278: 2318-2332. doi:10.1111/j.1742-4658.2011.08150.x.
25. Cheng F, Li W, Zhou Y, Shen J, Wu Z, et al. (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52: 3099-3105. doi:10.1021/ci300367a.
26. Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today: Technol 1: 337-341. doi:10.1016/j.ddtec.2004.11. 007.
27. Gautam MK, Gangwar M, Nath G, Rao CV, Goel RK (2012) In-vitro antibacterial activity on human pathogens and total phenolic, flavonoid contents of Murraya paniculata Linn. leaves. Asian Pac J Trop Biomed 2: S1660-S1663. doi:10.1016/S2221-1691(12)60472-9.
28. Klančnik A, Piskernik S, Jeršek B, Možina SS (2010) Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J Microbiol Methods 81: 121-126. doi:10.1016/j.mimet.2010.02.004.
29. Askun T, Tekwu EM, Satil F, Modanlioglu S, Aydeniz H (2013) Preliminary antimycobacterial study on selected Turkish plants (Lamiaceae) against Mycobacterium tuberculosis and search for some phenolic constituents. BMC Complem Altern Med 13: 365. doi:10.1186/1472-6882-13-365.
30. Krysan DJ, Didone L (2008) A high-throughput screening assay for small molecules that disrupt yeast cell integrity. J Biomol Screen 13: 657-664. doi:10.1177/1087057108320713.
31. Kitamura A, Someya K, Hata M, Nakajima R, Takemura M (2009) Discovery of a Small-Molecule Inhibitor of β-1,6-Glucan Synthesis. Antimicrob Agents Chemother 53: 670-677. doi:10.1128/AAC.00844-08.
32. Ene IV, Cheng S-C, Netea MG, Brown AJP (2013) Growth of Candida albicans cells on the physiologically relevant carbon source lactate affects their recognition and phagocytosis by immune cells. Infect Immun 81: 238-248. doi:10.1128/IAI.01092-12.
33. Merlot C (2010) Computational toxicology - a tool for early safety evaluation. Drug Discov Today 15: 16-22. doi:10.1016/j.drudis.2009.09.010.
34. Vasanthanathan P, Taboureau O, Oostenbrink C, Vermeulen NPE, Olsen L, et al. (2009) Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques. Drug Metab Dispos 37: 658-664. doi:10.1124/dmd.108.023507.
35. Lynch T, Price A (2007) The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76: 391-396. (Pubitemid 47219454)
36. Levin GM (2012) P-glycoprotein: why this drug transporter may be clinically important. Curr Psychiatry 11: 38-40.
37. Chuang C-M, Monie A, Wu A, Hung C-F (2009) Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. J Biomed Sc 16: 49. doi:10.1186/1423-0127-16-49.
38. Singh P, Mishra SK, Noel S, Sharma S, Rath SK (2012) Acute Exposure of Apigenin Induces Hepatotoxicity in Swiss Mice. PLoS ONE 7: e31964. doi:10.1371/journal.pone.0031964.
39. Zbidah M, Lupescu A, Jilani K, Fajol A, Michael D, et al. (2012) Apigenin-induced suicidal erythrocyte death. J Agric Food Chem 60: 533-538. doi:10.1021/jf204107f.
40. Gülçin İ (2006) Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicol 217: 213-220. doi:10.1016/j.tox.2005.09. 011.
41. Hirose M, Takesada Y, Tanaka H, Tamano S, Kato T, et al. (1998) Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model. Carcinogenesis 19: 207-212. (Pubitemid 28376844)
42. Petersen M, Simmonds MSJ (2003) Rosmarinic acid. Phytochem 62: 121-125. (Pubitemid 36857578)
43. Karthik D, Viswanathan P, Anuradha CV (2011) Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats. J Cardiovasc Pharmacol 58: 514-521. doi:10.1097/FJC.0b013e31822c265d.
44. De Oliveira NCD, Sarmento MS, Nunes EA, Porto CM, Rosa DP, et al. (2012) Rosmarinic acid as a protective agent against genotoxicity of ethanol in mice. Food Chem Toxicol 50: 1208-1214. doi:10.1016/j.fct.2012.01.028.
45. CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd informational supplement. M27-S3. Clinical and Laboratory Standards Institute, Wayne, PA.
46. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14: 398-405. doi:10.1111/j.1469-0691.2007.01935.x.
47. Chell RM, Sundaram TK, Wilkinson AE (1978) Isolation and characterization of isocitrate lyase from a thermophilic Bacillus sp. Biochem J 173: 165-177. (Pubitemid 8368289)